This year's RSNA meeting will something for everyone involved in the breast and OB/GYN imaging spaces.
Breast imaging has undergone many significant changes over the past decade alone, with emerging techniques like contrast-enhanced mammography (CEM) and ablative treatments gaining ground. Other modalities to be featured for breast imaging include whole-breast ultrasound, molecular imaging, and MRI among others.
Scientific sessions will also look at breast imaging as it relates to policy, such as screening performance with updated guidelines by the U.S. Preventive Services Task Force and the U.S. Food and Drug Administration (FDA)'s 2024 mandate on breast density notification.
And AI continues to emerge in clinical practice. Sessions will explore how AI can help with breast cancer detection and operational efficiency. Sessions will also examine how AI can help predict long-term cancer risk up to 10 years.
Meanwhile, in OB/GYN imaging, researchers continue to explore how pelvic ultrasound and MRI can help with diagnosing pregnancy complications and endometriosis. Session attendees can learn about risk stratification with these non-invasive tools with the goal of accurate diagnosis while potentially avoiding risky surgery.
RSNA attendees can also explore the technical exhibits to get an up-close view of new technologies that vendors will have on display, including new AI software and mammography, ultrasound, and MRI scanners. Attendees can also take advantage of the many educational sessions that can help them in their practice or be useful for practice administration and educating students. This includes sneak peeks of what the future may hold for radiologists in women’s imaging and other specialties.
Poster presentations will further showcase current trends in radiology, women's imaging included, as well as approaches that attendees may have not previously thought about.
Keep reading for highlights of just some of the many presentations scheduled for this year's meeting. You can also access the complete scientific and educational program on the RSNA 2026 website. See you in Chicago!
Screen-detected breast cancers linked to lower mortality
Sunday, November 29 | 10:30 a.m. to 11:30 a.m. | S2-SSBR01-4 | Room S404
In this presentation, researchers will report on how the method of breast cancer detection relates to survival at the population level.
AI linked to higher recall rates in screening mammography
Sunday, November 29 | 10:30 a.m. to 11:30 a.m. | S2-SSBR01-7 | Room S404
In this talk, researchers will share real-world results after comparing screening mammography interpretations with and without AI at a tertiary care cancer center.
DL risk model outperforms clinical assessment at safety net hospital
Monday, November 30 | 9:30 a.m. to 10:30 a.m. | M3-SSBR03-2 | Room S406A
Researchers will present the performance of the Mirai breast imaging AI model at a diverse urban safety net hospital.
AI risk model outperforms traditional tools across NCCN thresholds
Monday, November 30 | 9:30 a.m. to 10:30 a.m. | M3-SSBR03-7 | Room S406A
In this talk, researchers will compare an AI model with traditional clinical risk tools across NCCN-anchored and AI-derived thresholds.
AI risk tool targets supplemental breast MRI to cut early detection failures
Monday, November 30 | 9:30 a.m. to 10:30 a.m. | M3-SSBR04-1 | Room S402
Researchers will report results from the ScreenTrustMRI trial, which tested whether an AI risk predictor can select the women who would benefit most from supplemental MRI.
Elastography shows high accuracy for predicting gestational hypertension
Monday, November 30 | 9:30 a.m. to 10:30 a.m. | M3-SSOB01-7 | Room S404
In this session, a group will report on the performance of second-trimester shear wave placental elastography and uterine artery Doppler indices for predicting gestational hypertension.
Breast cryoablation improves quality of life in older women
Monday, November 30 | 1:30 p.m. to 2:30 p.m. | M6-SSIR01-2 | Room E353B
The treatment led to clinically significant improvement in quality of life at 12 months, researchers have found.
AI helps narrow experience gap between mammography readers
Tuesday, December 1 | 9:30 a.m. to 10:30 p.m. | T3-SSBR05-6 | Room S406A
Researchers will report whether AI-assisted mammography improves diagnostic performance differently for junior and senior readers and whether it narrows experience-related performance gaps.
MRI reveals greater disease extent, hidden invasive cancer in low-risk DCIS
Tuesday, December 1 | 3:00 p.m. to 4:00 p.m. | T7-SSBR06-7 | Room N227B
Here, attendees will learn how preoperative MRI helps in women with low-risk, screen-detected ductal carcinoma in situ (DCIS).
O-RADS MRI spots ovarian cancer in women with endometriosis
Tuesday, December 1 | 3:00 p.m. to 4:00 p.m. | T7-SSOB02-7 | Room S404
In this presentation, attendees will find out how well MRI identifies endometriosis-associated ovarian malignancy.
Breast cryoablation could pay its way in imaging practices
Wednesday, December 2 | 10:10 a.m. to 10:20 a.m. | W3-SSBR08-5 | Room S406A
Researchers will discuss the financial impact of launching a breast cancer cryoablation service line within an existing breast imaging practice.
Handheld screening ultrasound has blind spots
Thursday, December 3 | 1:30 p.m. to 2:30 p.m. | R6-SSBR11-4 | Room S406A
In this presentation, researchers will examine which factors affect cancer detection on technologist-performed handheld screening whole-breast ultrasound (WBUS).